New hope for diabetic nerve pain? long-term safety study of engensis shows promise

NCT ID NCT04055090

First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 31 times

Summary

This study looked at the long-term safety of a drug called Engensis (VM202) for people with painful diabetic peripheral neuropathy. It followed 101 adults who had already received Engensis or a placebo in an earlier study. The main goal was to see if the drug remained safe over 6 months and whether it continued to help with pain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Arizona Research Center

    Phoenix, Arizona, 85023, United States

  • Center for Clinical Research

    San Francisco, California, 94115, United States

  • Clinical Research of West Florida

    Tampa, Florida, 33603, United States

  • Clinical Trials, Inc.

    Little Rock, Arkansas, 72205, United States

  • Diablo Clinical Research, Inc.

    Walnut Creek, California, 94598, United States

  • EVMS (Eastern Virginia Medical School)

    Norfolk, Virginia, 23510, United States

  • Innovative Research of West Florida

    Clearwater, Florida, 33756, United States

  • Nerve and Muscle Center of Texas

    Houston, Texas, 77030, United States

  • Neurological Research Institute

    Santa Monica, California, 90404, United States

  • Northern California Research

    Sacramento, California, 95821, United States

  • Rainier Clinical Research Center, Inc.

    Renton, Washington, 98057, United States

  • Raleigh Neurology Associates, P.A.

    Raleigh, North Carolina, 27607, United States

  • The Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • University of Florida McKnight Brain Institute

    Gainesville, Florida, 32611, United States

Conditions

Explore the condition pages connected to this study.